[CAS NO. 520-85-4] Medroxyprogesterone

Ships within

Stock

Price

Qty

Total

Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.

MDL	-
Molecular Weight	344.49
Molecular Formula	C22H32O3
SMILES	C[C@@]1([C@@]2(O)C(C)=O)[C@](CC2)([H])[C@@](C[C@H](C)C3=CC4=O)([H])[C@]([C@]3(CC4)C)([H])CC1

NCT Number	Sponsor	Condition	Start Date	Phase
NCT00004650	National Institute of Dental and Craniofacial Research (NIDCR)\|Washington University School of Medicine\|Office of Rare Diseases (ORD)	Osteoporosis	August 1993	Phase 3
NCT00577122	Indiana University\|Translational Breast Cancer Research Consortium	Estrogen Receptor-negative Breast Cancer\|Progesterone Receptor-negative Breast Cancer\|Recurrent Breast Cancer\|Stage IV Breast Cancer	July 2007	Phase 2
NCT00000466	National Heart, Lung, and Blood Institute (NHLBI)\|National Institute on Aging (NIA)\|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Bone Diseases\|Cardiovascular Diseases\|Coronary Disease\|Diabetes Mellitus\|Heart Diseases\|Hypercholesterolemia\|Hypertension\|Myocardial Ischemia\|Osteoporosis\|Thrombosis\|Postmenopause	September 1987	Phase 3
NCT00033358	National Cancer Institute (NCI)	Endometrial Cancer	February 2002	Phase 2
NCT00016601	National Institute of Allergy and Infectious Diseases (NIAID)\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HIV Infections	June 2001	Not Applicable
NCT01143207	FHI 360\|Eastern Virginia Medical School	Contraception	May 2010	Not Applicable
NCT00044837	National Institute of Allergy and Infectious Diseases (NIAID)	HIV Infections		Phase 1
NCT05247268	Fudan University\|Peking Union Medical College Hospital	Endometrial Neoplasm Malignant Stage I	March 11, 2022	Phase 2
NCT00319566	University of California, San Francisco\|Wyeth is now a wholly owned subsidiary of Pfizer	Coronary Heart Disease	July 1992	Phase 3
NCT01776203	Kaiser Permanente	Dysfunctional Uterine Bleeding	January 2012	Phase 4
NCT02228681	Gynecologic Oncology Group\|Novartis Pharmaceuticals\|GOG Foundation	Advanced, Persistent, or Recurrent Endometrial Cancer	February 2015	Phase 2
NCT01148420	Women´s Health Care Clinic, Torrance, California	Dysfunctional Uterine Bleeding	January 2009	Phase 4
NCT00064025	Gynecologic Oncology Group\|National Cancer Institute (NCI)\|GOG Foundation	Endometrial Adenocarcinoma\|Endometrial Adenosquamous Carcinoma\|Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation\|Recurrent Uterine Corpus Carcinoma\|Stage I Uterine Corpus Cancer\|Stage II Uterine Corpus Cancer\|Stage III Uterine Corpus Cancer\|Stage IV Uterine Corpus Cancer	April 2004	Phase 2
NCT02509767	Planned Parenthood Federation of America\|Pfizer\|Tara Health Foundation	Contraception	August 2015	Phase 4
NCT03018249	National Cancer Institute (NCI)\|NRG Oncology	FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma\|FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma\|FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma	October 11, 2017	Early Phase 1
NCT00066157	University of Wisconsin, Madison\|National Institute on Aging (NIA)	Alzheimer Disease	September 2001	Phase 2\|Phase 3
NCT01791413	Mahidol University	Endometriosis	March 2012	Phase 1\|Phase 2
NCT00360490	Bayer	Menorrhagia	July 2006	Phase 3
NCT00291369	Centre Leon Berard\|French Immunotherapy Intergroup\|SCAPP (Sub-Cutaneous Administration Proleukin Program)	Metastatic Renal Cell Carcinoma	December 1999	Phase 3
NCT00437658	AbbVie	Endometriosis	December 11, 2006	Phase 2
NCT01822288	Far Eastern Memorial Hospital	Menopausal Syndromes	November 16, 2012	Phase 4
NCT05565573	Hua Li\|Beijing Chao Yang Hospital	Fertility Sparing	November 1, 2022	Phase 2\|Phase 3
NCT00083824	Tufts University\|National Heart, Lung, and Blood Institute (NHLBI)	Cardiovascular Diseases\|Coronary Disease\|Heart Diseases\|Coronary Arteriosclerosis	March 2004	Phase 2\|Phase 3
NCT00169299	Kaiser Permanente\|National Institute on Aging (NIA)\|National Center for Complementary and Integrative Health (NCCIH)	Vasomotor Symptoms Associated With Menopause	June 2001	Phase 4
NCT02579590	Assiut University	Female Sexual Function	May 1, 2017
NCT04710017	Assiut University	Uterine Bleeding	February 1, 2021	Not Applicable
NCT00420342	Bayer	Postmenopause\|Hypertension\|Pre-Hypertension	January 2007	Phase 2
NCT00828542	University of Sao Paulo	Breastfeeding\|Contraception	July 2007	Not Applicable
NCT02894151	Chulalongkorn University	Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS	April 2015	Phase 2
NCT01019369	Carolyn L. Westhoff\|Family Planning Fellowship\|Pfizer\|Columbia University	Contraception	March 2010	Not Applicable
NCT00997893	University of Illinois at Chicago\|National Institute of Mental Health (NIMH)	Menopause\|Hot Flashes	December 2009	Phase 2
NCT03660046	Emory University\|National Institutes of Health (NIH)\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Hormonal Contraception	December 7, 2018
NCT03097120	Wake Forest University Health Sciences\|National Heart, Lung, and Blood Institute (NHLBI)	Heart Disease	January 1995	Phase 3
NCT03675139	Xiaojun Chen\|Fudan University	Endometrial Hyperplasia Without Atypia	February 26, 2019	Phase 2\|Phase 3
NCT01472315	Turku University Hospital	Sleep Apnea	January 2000	Phase 2\|Phase 3
NCT01463202	Beatrice Chen\|Society of Family Planning\|University of Pittsburgh	Contraception\|Postpartum Depression\|Lactation	November 2011	Phase 4
NCT01011751	Takeda	Adenocarcinoma, Prostate	April 2004	Phase 3
NCT00830414	Teva Pharmaceuticals USA	Healthy	April 2002	Phase 1
NCT01074892	University Hospital of North Norway\|Helse Nord\|Norwegian Cancer Society	Endometrial Hyperplasia	May 2005	Phase 4
NCT01056042	Prince of Songkla University	Endometriosis	June 2007	Phase 4
NCT00332553	Eli Lilly and Company	Vasomotor Symptoms\|Endometrial Safety	February 2002	Phase 2
NCT00000559	National Heart, Lung, and Blood Institute (NHLBI)	Cardiovascular Diseases\|Coronary Disease\|Heart Diseases\|Myocardial Ischemia\|Postmenopause	March 1995	Phase 3
NCT02103764	Mahidol University	Dysfunctional Uterine Bleeding	August 2013	Phase 3
NCT00743574	Yale University\|National Center for Research Resources (NCRR)	Polycystic Ovarian Syndrome\|Vitamin D Deficiency	August 2008	Not Applicable
NCT03309176	Radboud University Medical Center	Ovulation Disorder	June 21, 2016	Phase 4
NCT04669678	University of Washington\|Merck Sharp & Dohme LLC\|Wits Reproductive Health and HIV Institute	HIV Infections\|Contraception\|Drug-drug Interaction	November 17, 2021
NCT00416429	Centre Leon Berard	Kidney Cancer		Phase 3
NCT04910711	Botswana Harvard AIDS Institute Partnership\|University of Liverpool	Human Immunodeficiency Virus\|Contraception\|ART	October 21, 2021	Phase 4
NCT05491343	HaEmek Medical Center, Israel	Arteriovenous Malformations	August 2022	Phase 4
NCT01461824	Nationwide Children´s Hospital\|Society of Family Planning	Weight Gain\|Disorder of Bone Density and Structure, Unspecified\|Uterine Bleeding	September 2011	Phase 3
NCT00191113	Eli Lilly and Company	Turner Syndrome	February 1989	Phase 3
NCT02272647	Mayo Clinic	Healthy	December 2014	Phase 1
NCT00006133	National Center for Research Resources (NCRR)\|University of Alabama at Birmingham	Systemic Lupus Erythematosus	June 2000	Not Applicable
NCT05255653	Leiden University Medical Center\|Institute Gustave Roussy (sponsor p53abn-RED trial)\|Leiden University Medical center (sponsor MMRd-GREEN trial)\|University College London (sponsor NSMP-ORANGE trial)\|Canadian Clinical Trials Group (sponsor POLEmut-BLUE trial)\|Dutch Gynaecological Oncology Group\|Comprehensive Cancer Centre The Netherlands\|Cancer Research UK & UCL Cancer Trials Centre\|Dutch Cancer Society\|AstraZeneca	Endometrial Cancer	November 11, 2021	Phase 2\|Phase 3
NCT02357368	Lisa Haddad\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\|Emory University	HIV\|Contraception	February 2015	Phase 4
NCT02412436	AIDS Clinical Trials Group\|National Institute of Allergy and Infectious Diseases (NIAID)	HIV-1 Infection\|Tuberculosis	November 3, 2015	Phase 2
NCT00030914	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Hot Flashes	April 2002	Phase 3
NCT02872818	Kayseri Education and Research Hospital	Apoptotic Signal Pathways in Endometrial Hyperplasia	October 2014	Phase 4
NCT04654741	Casa di Cura Privata Villa Mafalda	IVF\|Infertility	September 1, 2020	Phase 4
NCT00739830	Merck Sharp & Dohme LLC	Endometrial Cancer	August 2008	Phase 2
NCT00002920	Southwest Oncology Group\|National Cancer Institute (NCI)\|Cancer and Leukemia Group B	Breast Cancer\|Endometrial Cancer	March 1997	Phase 3
NCT00026286	Eastern Cooperative Oncology Group\|National Cancer Institute (NCI)	Breast Cancer\|Hot Flashes\|Menopausal Symptoms	September 2000	Phase 3
NCT04997811	Prof. Janet Dunn\|Blood Cancer UK\|Dudley Group NHS Foundation Trust\|University of Birmingham\|University of Manchester\|King´s College Hospital NHS Trust\|University of Warwick	Myelodysplastic Syndromes (MDS)	December 21, 2021	Phase 2
NCT02943655	Assiut University	Improve Quality of Life\|Heavy Menstrual Bleeding	November 1, 2017	Phase 3
NCT00006324	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\|National Institute of Allergy and Infectious Diseases (NIAID)	HIV Infections	December 1999	Not Applicable
NCT02340013	Samuel Lunenfeld Research Institute, Mount Sinai Hospital\|University of Toronto	Infertility	July 2013	Phase 4
NCT00091728	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Chlamydia Infection\|Neisseriaceae Infection	September 1997
NCT02335203	Women and Infants Hospital of Rhode Island	Grade 1 Endometrial Endometrioid Adenocarcinoma\|Grade 2 Endometrial Endometrioid Adenocarcinoma\|Complex Atypical Endometrial Hyperplasia	February 2015	Phase 2
NCT00000605	National Heart, Lung, and Blood Institute (NHLBI)	Cardiovascular Diseases\|Coronary Arteriosclerosis\|Coronary Disease\|Heart Diseases\|Myocardial Ischemia\|Postmenopause	August 1996	Phase 3
NCT01191203	Emory University\|University of North Carolina\|National Institute of Allergy and Infectious Diseases (NIAID)	HIV	July 2010	Not Applicable
NCT00003179	Gynecologic Oncology Group\|National Cancer Institute (NCI)\|GOG Foundation	Endometrial Cancer	November 1998	Phase 2
NCT02122198	University of Colorado, Denver	Cognitive Impairment\|Executive Dysfunction\|Endothelial Dysfunction\|Cardiovascular Disease	September 8, 2014	Not Applicable
NCT00808132	Pfizer	Menopause\|Osteoporosis	January 2009	Phase 3

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.

Catalog:	HY-B0648
Brand:	MCE
CAS:	520-85-4

1 mM	2.9028 mL	14.5142 mL	29.0284 mL
5 mM	0.5806 mL	2.9028 mL	5.8057 mL
10 mM	0.2903 mL	1.4514 mL	2.9028 mL

[CAS NO. 520-85-4] Medroxyprogesterone

Overview

7 Publications Citing Use of MCE

Summary

Clinical Trial

Appearance

Shipping

Storage

Solvent & Solubility

References

Synonyms